INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.
This study has been completed.
Study NCT00615134
Information provided by Hoffmann-La Roche
First Received on January 30, 2008.
Last Updated on May 23, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
